Header

Waldenstrom's Macroglobulinemia Clinical Trials

Category:Adult
Status:Active

Displaying 1 trial

A Study of Daratumumab in Patients With Relapsed or Refractory Waldenström Macroglobulinemia

This research study is studying Daratumumab as a possible treatment for Waldenström Macroglobulinemia.

Diagnosis: Waldenstrom's Macroglobulinemia, Multiple Myeloma

Phase:

Protocol Number: 17-164

'